dir_names,sample_name,treatment
1-16081_Nor_Cells_AGTCAAAT_L001_,1-16081,normoxia_cells
13-16143_Nor_Cells_CGATGTAT_L001_,13-16143,normoxia_cells
17-No_1_16081_Nor_EV_AGTTCCAT_L001_,17-No_1_16081,normoxia_ev
18-No_2_16082_Nor_EV_TTAGGCAT_L001_,18-No_2_16082,normoxia_ev
19-No_3_16088_Nor_EV_TGACCAAT_L001_,19-No_3_16088,normoxia_ev
20-No_4_16143_Nor_EV_ACAGTGAT_L001_,20-No_4_16143,normoxia_ev
21-No_5_16081_Hyp_EV_GCCAATAT_L001_,21-No_5_16081,hypoxia_ev
22-No_6_16082_Hyp_EV_ATGTCAAT_L001_,22-No_6_16082,hypoxia_ev
23-No_7_16088_Hyp_EV_CAGATCAT_L001_,23-No_7_16088,hypoxia_ev
24-No_8_16143_Hyp_EV_ACTTGAAT_L001_,24-No_8_16143,hypoxia_ev
25-No_9_16081_N_P_EV_GATCAGAT_L001_,25-No_9_16081,normoxia_primed_ev
26-No_10_16082_N_P_EV_TAGCTTAT_L001_,26-No_10_16082,normoxia_primed_ev
27-No_11_16088_N_P_EV_CCGTCCAT_L001_,27-No_11_16088,normoxia_primed_ev
28-No_12_16143_N_P_EV_GTAGAGAT_L001_,28-No_12_16143,normoxia_primed_ev
29-No_13_16082_Nor_Cells_GTGAAAAT_L001_,29-No_13_16082,normoxia_cells
31-No_15_FBS_EV_GTCCGCAT_L001_,31-No_15_FBS,fbs_control
9-16088_Nor_Cells_ATCACGAT_L001_,9-16088,normoxia_cells
